CA Stock MarketDetailed Quotes

MRV Nuvo Pharmaceuticals Inc

Watchlist
  • 1.350
  • 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
15.37MMarket Cap-19285P/E (TTM)

Nuvo Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments
10.03%31.26M
4.83%28.58M
11.76%26.55M
29.68%30.87M
29.68%30.87M
34.59%28.41M
58.91%27.27M
45.72%23.75M
3.42%23.81M
3.42%23.81M
-Cash and cash equivalents
10.03%31.26M
4.83%28.58M
11.76%26.55M
29.68%30.87M
29.68%30.87M
34.59%28.41M
58.91%27.27M
45.72%23.75M
3.42%23.81M
3.42%23.81M
-Accounts receivable
18.86%10.05M
11.80%9.71M
14.30%9.65M
-12.86%6.53M
-12.86%6.53M
-14.91%8.46M
-29.95%8.69M
-45.53%8.44M
-47.95%7.49M
-47.95%7.49M
Total current assets
3.57%51.83M
6.41%50.28M
12.33%49.95M
15.92%50.7M
15.92%50.7M
17.83%50.04M
13.52%47.25M
-4.06%44.47M
-7.38%43.74M
-7.38%43.74M
Non current assets
-Accumulated depreciation
----
----
----
6.42%-5.18M
6.42%-5.18M
----
----
----
-6.75%-5.53M
-6.75%-5.53M
-Long term equity investment
-1.46%84.57M
-5.01%81.28M
-8.97%80.53M
-8.75%83.37M
-8.75%83.37M
-18.36%85.82M
-21.93%85.57M
-24.50%88.46M
-12.98%91.36M
-12.98%91.36M
-Goodwill
-11.19%71.68M
-25.44%71.67M
-25.27%73.46M
-25.17%75.53M
-25.17%75.53M
-24.51%80.7M
-12.36%96.13M
-13.69%98.3M
-9.18%100.93M
-9.18%100.93M
Regulatory assets
-8.48%10.07M
9.16%9.8M
36.49%12.06M
13.84%9.24M
13.84%9.24M
6.96%11M
-35.90%8.98M
-56.32%8.84M
-46.16%8.11M
-46.16%8.11M
Non current deferred assets
----
----
----
----
----
-94.39%143K
-6.66%2.38M
-14.43%2.5M
731.41%2.59M
731.41%2.59M
Liabilities
Current liabilities
Current debt and capital lease obligation
7.58%12.98M
3.97%12.2M
-0.62%11.84M
0.02%12.34M
0.02%12.34M
90.27%12.07M
78.70%11.74M
117.30%11.91M
-32.90%12.34M
-32.90%12.34M
-Current debt
7.58%12.98M
3.97%12.2M
-0.62%11.84M
0.02%12.34M
0.02%12.34M
90.27%12.07M
78.70%11.74M
117.30%11.91M
-32.90%12.34M
-32.90%12.34M
-accounts payable
12.57%10.41M
3.77%10.45M
30.28%12.61M
38.20%11.49M
38.20%11.49M
28.93%9.25M
44.13%10.07M
1.65%9.68M
-14.09%8.31M
-14.09%8.31M
-Total tax payable
-20.23%94.19M
-18.37%93.84M
-11.21%110.43M
6.28%116.53M
6.28%116.53M
-3.72%118.07M
-5.75%114.96M
-1.92%124.38M
-0.82%109.65M
-0.82%109.65M
Current liabilities
7.43%24.59M
0.44%23.16M
15.03%26.02M
15.78%25.19M
15.78%25.19M
52.42%22.89M
48.16%23.06M
25.31%22.62M
-23.51%21.76M
-23.51%21.76M
Non current liabilities
Non current accrued expenses
-9.49%3.76M
-10.42%3.85M
-11.03%3.96M
-8.92%4.1M
-8.92%4.1M
-1.89%4.15M
-3.72%4.3M
-3.39%4.45M
0.99%4.51M
0.99%4.51M
Derivative product liabilities
-88.23%3.3M
-73.19%6.66M
-19.51%25.69M
113.39%29.16M
113.39%29.16M
110.23%28.02M
201.07%24.85M
571.96%31.92M
513.06%13.67M
513.06%13.67M
Long term provisions
-1.46%84.57M
-5.01%81.28M
-8.97%80.53M
-8.75%83.37M
-8.75%83.37M
-18.36%85.82M
-21.93%85.57M
-24.50%88.46M
-12.98%91.36M
-12.98%91.36M
Total non current liabilities
-15.74%118.77M
-15.23%117M
-7.18%136.45M
7.85%141.72M
7.85%141.72M
2.40%140.96M
0.35%138.02M
1.48%147M
-5.46%131.4M
-5.46%131.4M
Shareholders'equity
Share capital
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
-common stock
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
0.00%184.76M
Additional paid-in capital
1.02%16.5M
1.09%16.47M
1.40%16.48M
1.42%16.38M
1.42%16.38M
1.47%16.34M
1.53%16.3M
1.61%16.25M
1.64%16.15M
1.64%16.15M
Gains losses not affecting retained earnings
-497.34%-747K
-89.29%45K
53.77%449K
597.30%258K
597.30%258K
-71.86%188K
147.06%420K
106.60%292K
158.73%37K
158.73%37K
Other equity interest
7.32%2.16M
6.91%2.4M
139.71%2.17M
----
----
--2.01M
--2.24M
--904K
----
----
Total equity
-5.76%127.26M
-16.17%125.8M
-14.93%127.38M
-14.12%130.33M
-14.12%130.33M
-13.52%135.04M
-5.22%150.06M
-10.76%149.72M
-6.97%151.77M
-6.97%151.77M
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments 10.03%31.26M4.83%28.58M11.76%26.55M29.68%30.87M29.68%30.87M34.59%28.41M58.91%27.27M45.72%23.75M3.42%23.81M3.42%23.81M
-Cash and cash equivalents 10.03%31.26M4.83%28.58M11.76%26.55M29.68%30.87M29.68%30.87M34.59%28.41M58.91%27.27M45.72%23.75M3.42%23.81M3.42%23.81M
-Accounts receivable 18.86%10.05M11.80%9.71M14.30%9.65M-12.86%6.53M-12.86%6.53M-14.91%8.46M-29.95%8.69M-45.53%8.44M-47.95%7.49M-47.95%7.49M
Total current assets 3.57%51.83M6.41%50.28M12.33%49.95M15.92%50.7M15.92%50.7M17.83%50.04M13.52%47.25M-4.06%44.47M-7.38%43.74M-7.38%43.74M
Non current assets
-Accumulated depreciation ------------6.42%-5.18M6.42%-5.18M-------------6.75%-5.53M-6.75%-5.53M
-Long term equity investment -1.46%84.57M-5.01%81.28M-8.97%80.53M-8.75%83.37M-8.75%83.37M-18.36%85.82M-21.93%85.57M-24.50%88.46M-12.98%91.36M-12.98%91.36M
-Goodwill -11.19%71.68M-25.44%71.67M-25.27%73.46M-25.17%75.53M-25.17%75.53M-24.51%80.7M-12.36%96.13M-13.69%98.3M-9.18%100.93M-9.18%100.93M
Regulatory assets -8.48%10.07M9.16%9.8M36.49%12.06M13.84%9.24M13.84%9.24M6.96%11M-35.90%8.98M-56.32%8.84M-46.16%8.11M-46.16%8.11M
Non current deferred assets ---------------------94.39%143K-6.66%2.38M-14.43%2.5M731.41%2.59M731.41%2.59M
Liabilities
Current liabilities
Current debt and capital lease obligation 7.58%12.98M3.97%12.2M-0.62%11.84M0.02%12.34M0.02%12.34M90.27%12.07M78.70%11.74M117.30%11.91M-32.90%12.34M-32.90%12.34M
-Current debt 7.58%12.98M3.97%12.2M-0.62%11.84M0.02%12.34M0.02%12.34M90.27%12.07M78.70%11.74M117.30%11.91M-32.90%12.34M-32.90%12.34M
-accounts payable 12.57%10.41M3.77%10.45M30.28%12.61M38.20%11.49M38.20%11.49M28.93%9.25M44.13%10.07M1.65%9.68M-14.09%8.31M-14.09%8.31M
-Total tax payable -20.23%94.19M-18.37%93.84M-11.21%110.43M6.28%116.53M6.28%116.53M-3.72%118.07M-5.75%114.96M-1.92%124.38M-0.82%109.65M-0.82%109.65M
Current liabilities 7.43%24.59M0.44%23.16M15.03%26.02M15.78%25.19M15.78%25.19M52.42%22.89M48.16%23.06M25.31%22.62M-23.51%21.76M-23.51%21.76M
Non current liabilities
Non current accrued expenses -9.49%3.76M-10.42%3.85M-11.03%3.96M-8.92%4.1M-8.92%4.1M-1.89%4.15M-3.72%4.3M-3.39%4.45M0.99%4.51M0.99%4.51M
Derivative product liabilities -88.23%3.3M-73.19%6.66M-19.51%25.69M113.39%29.16M113.39%29.16M110.23%28.02M201.07%24.85M571.96%31.92M513.06%13.67M513.06%13.67M
Long term provisions -1.46%84.57M-5.01%81.28M-8.97%80.53M-8.75%83.37M-8.75%83.37M-18.36%85.82M-21.93%85.57M-24.50%88.46M-12.98%91.36M-12.98%91.36M
Total non current liabilities -15.74%118.77M-15.23%117M-7.18%136.45M7.85%141.72M7.85%141.72M2.40%140.96M0.35%138.02M1.48%147M-5.46%131.4M-5.46%131.4M
Shareholders'equity
Share capital 0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M
-common stock 0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M0.00%184.76M
Additional paid-in capital 1.02%16.5M1.09%16.47M1.40%16.48M1.42%16.38M1.42%16.38M1.47%16.34M1.53%16.3M1.61%16.25M1.64%16.15M1.64%16.15M
Gains losses not affecting retained earnings -497.34%-747K-89.29%45K53.77%449K597.30%258K597.30%258K-71.86%188K147.06%420K106.60%292K158.73%37K158.73%37K
Other equity interest 7.32%2.16M6.91%2.4M139.71%2.17M----------2.01M--2.24M--904K--------
Total equity -5.76%127.26M-16.17%125.8M-14.93%127.38M-14.12%130.33M-14.12%130.33M-13.52%135.04M-5.22%150.06M-10.76%149.72M-6.97%151.77M-6.97%151.77M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg